Silverberg Bernstein Capital Management LLC Volitionrx LTD Transaction History
Silverberg Bernstein Capital Management LLC
- $146 Billion
- Q2 2025
A detailed history of Silverberg Bernstein Capital Management LLC transactions in Volitionrx LTD stock. As of the latest transaction made, Silverberg Bernstein Capital Management LLC holds 200,782 shares of VNRX stock, worth $148,578. This represents 0.1% of its overall portfolio holdings.
Number of Shares
200,782
Previous 140,573
42.83%
Holding current value
$148,578
Previous $80.1 Million
90.41%
% of portfolio
0.1%
Previous 0.07%
Shares
6 transactions
Others Institutions Holding VNRX
# of Institutions
24Shares Held
21.3MCall Options Held
0Put Options Held
0-
Lagoda Investment Management, L.P. New York, NY10.2MShares$7.54 Million3.7% of portfolio
-
Armistice Capital, LLC New York, NY8.21MShares$6.07 Million0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA762KShares$563,8430.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA706KShares$522,4840.0% of portfolio
-
Black Rock Inc. New York, NY516KShares$381,8940.0% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $42.4M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...